ASAIO Journal最新文献

筛选
英文 中文
Left Ventricular Unloading With Self-Expanding Pump During Venoarterial Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction. 急性心肌梗死静脉体外膜氧合过程中自扩张泵左心室卸载。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-13 DOI: 10.1097/MAT.0000000000002920
Weiting Cai, Juan Ma, Nan Bai, Qianlan Xi, I-Wen Wang, Ming Bai, Andong Lu
{"title":"Left Ventricular Unloading With Self-Expanding Pump During Venoarterial Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction.","authors":"Weiting Cai, Juan Ma, Nan Bai, Qianlan Xi, I-Wen Wang, Ming Bai, Andong Lu","doi":"10.1097/MAT.0000000000002920","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002920","url":null,"abstract":"<p><p>Increased left ventricular (LV) afterload and distension during venoarterial extracorporeal membrane oxygenation (VA-ECMO) support may impede myocardial perfusion in acute myocardial infarction (AMI). Active LV unloading has been associated with improved outcomes. We report the first clinical use of a self-expanding percutaneous ventricular assist device (NyokAssist; magAssist, Suzhou, China) for LV unloading during VA-ECMO in a 56 year old man with AMI-related cardiogenic shock (CS). Successful coronary angiography and percutaneous coronary intervention (PCI) of the culprit left circumflex (LCx) lesion were performed with NyokAssist + VA-ECMO support. The patient was successfully weaned from VA-ECMO on post-procedure day 5 and remained on NyokAssist support alone for an additional 7 days before being transferred on VA-ECMO to a heart transplant center for consideration of advanced heart failure therapies due to limited myocardial recovery. No device-related complications were observed. This case demonstrates the technical feasibility of early implementation of a combined VA-ECMO and NyokAssist support strategy, enabling LV unloading, temporary hemodynamic stabilization, end-organ improvement, and VA-ECMO decannulation in a patient with AMI-related CS. As this report describes a single-patient experience, further clinical studies are warranted to define the safety, efficacy, and potential role of the use of NyokAssist in combination with VA-ECMO in the management of AMI-related CS.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serologic Guidance for Extracorporeal Membrane Oxygenation Selection and Survival Using the Cosmos Dataset. 使用Cosmos数据集进行体外膜氧合选择和生存的血清学指导。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-12 DOI: 10.1097/MAT.0000000000002893
Laura R Dell'Aiera, Ralph Ward, Luca Paoletti, Alicha Gibbs, Mary Dooley, Kit Simpson, David Fitzgerald
{"title":"Serologic Guidance for Extracorporeal Membrane Oxygenation Selection and Survival Using the Cosmos Dataset.","authors":"Laura R Dell'Aiera, Ralph Ward, Luca Paoletti, Alicha Gibbs, Mary Dooley, Kit Simpson, David Fitzgerald","doi":"10.1097/MAT.0000000000002893","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002893","url":null,"abstract":"<p><p>Extracorporeal membrane oxygenation (ECMO) is a life-support therapy for patients with severe cardiac or respiratory failure. Despite its growing use, evidence-based guidelines for ECMO candidacy remain limited due to small, single-center studies and heterogeneous designs. This study leveraged Epic Cosmos, an electronic health record dataset encompassing over 300 million patient records, to analyze outcomes among 42,210 adults treated with ECMO between January 1, 2019, and February 15, 2026, involving 23,116 (54.8%) venoarterial (VA), 14,632 (34.7%) venovenous (VV), and 4,462 (10.6%) hybrid (VA and VV) cases. Hospital mortality varied from 37% (VV) to 50% (VA). Poisson models by ECMO type for in-hospital mortality adjusted for key demographic and clinical variables showed the admitting diagnosis group had the strongest association with subsequent mortality. Several blood chemistry markers measured within the 24 hours before ECMO initiation were also associated with increased mortality, including elevated lactate, elevated creatinine, and lower pH, though strength of association varied by ECMO type. Our findings support the use of large electronic health record (EHR) datasets for ECMO outcomes research and identify exploratory associations between preinitiation biomarkers and in-hospital mortality that require further validation.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149392699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External Validation of a Risk Score Assessment for Pediatric Ventricular Assist Device Mortality. 儿童心室辅助装置死亡率风险评分评估的外部验证。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-09 DOI: 10.1097/MAT.0000000000002898
Meaghan Reaney, Katerina Boucek, Angela Lorts, David N Rosenthal, Ke Yan, Jian Zhang, Robert Aaron Niebler
{"title":"External Validation of a Risk Score Assessment for Pediatric Ventricular Assist Device Mortality.","authors":"Meaghan Reaney, Katerina Boucek, Angela Lorts, David N Rosenthal, Ke Yan, Jian Zhang, Robert Aaron Niebler","doi":"10.1097/MAT.0000000000002898","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002898","url":null,"abstract":"<p><p>The ACTION score was internally validated to predict mortality after pediatric ventricular assist device (VAD) placement. This study aims to externally validate the ACTION score and compare its performance to the INTERMACS profile for prediction of mortality in pediatric VAD candidates. The publicly available Pedimacs dataset (531 patients) was used for external validation. The Pedimacs dataset as well as a contemporary ACTION dataset (1,304 patients) were used to compare the performance of the ACTION score and INTERMACS profile. A statistically significant linear trend in the proportion of death across increasing ACTION scores (p < 0.0001) was observed in the Pedimacs dataset, with a receiver operating characteristic (ROC) curve demonstrating an area under the curve (AUC) of 0.71. Both the ACTION score and the INTERMACS profile demonstrated a significant linear trend in the proportion of death across scores in the ACTION dataset. Receiver operating characteristic analysis demonstrated an AUC of 0.71 and 0.58 for the ACTION score and INTERMACS profile, respectively. The ACTION score is externally validated with the Pedimacs dataset and is a fair predictor of mortality. The ACTION score performed better than the INTERMACS profile in predicting mortality using both historical Pedimacs data and contemporary ACTION data.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning to Live With a Ventricular Assist Device: Patient, Caregiver, and Clinician Concerns Following Implantation and Hospital Discharge. 学习使用心室辅助装置:患者、护理人员和临床医生在植入和出院后的关注。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-09 DOI: 10.1097/MAT.0000000000002916
Rebecca S Harap, Jeffrey H Barsuk, Elaine R Cohen, Jane E Wilcox, Kathleen L Grady, Kerry B Shanklin, Diane B Wayne, Kenzie A Cameron
{"title":"Learning to Live With a Ventricular Assist Device: Patient, Caregiver, and Clinician Concerns Following Implantation and Hospital Discharge.","authors":"Rebecca S Harap, Jeffrey H Barsuk, Elaine R Cohen, Jane E Wilcox, Kathleen L Grady, Kerry B Shanklin, Diane B Wayne, Kenzie A Cameron","doi":"10.1097/MAT.0000000000002916","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002916","url":null,"abstract":"<p><p>Patients undergoing ventricular assist device (VAD) implantation and their caregivers must attain knowledge and skills to perform VAD self-care safely. Little is known about the similarities and differences among patients, caregivers, and VAD clinicians related to VAD self-care training and management. This study explored the perspectives of 15 VAD patients, 12 VAD caregivers, and 18 VAD clinicians through individual semi-structured interviews focused on understanding barriers related to VAD self-care training and concerns about VAD self-care post-discharge. We identified four major themes (training related, care transitions, fear and uncertainty, clinical consequences). All participant groups discussed concerns related to daily VAD self-care and the transition home after implantation. Caregivers and clinicians discussed the steep VAD self-care learning curve. Caregivers and patients discussed fears in general (eg, constant fear) and specific terms (eg, VAD malfunction), whereas clinicians who discussed fear/uncertainty identified strategies for dealing with emergent situations. Concerns regarding adverse events and non-adherence arose primarily from clinicians. Although some alignment was found, concerns varied among stakeholders. A common understanding of these nuanced concerns may improve VAD self-care training and the preparation of patients and caregivers.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal Membrane Oxygenation in Patients With Pulmonary Hemorrhage. 肺出血患者的体外膜氧合。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-09 DOI: 10.1097/MAT.0000000000002905
Matthias Raes, Tim Balthazar, Michaël Mekeirele, Wilfried Cools, Jeroen Blanckaert, Ines Van Loo, Maximilian Malfertheiner, Fabio Silvio Taccone, Mirko Belliato, Justyna Swol
{"title":"Extracorporeal Membrane Oxygenation in Patients With Pulmonary Hemorrhage.","authors":"Matthias Raes, Tim Balthazar, Michaël Mekeirele, Wilfried Cools, Jeroen Blanckaert, Ines Van Loo, Maximilian Malfertheiner, Fabio Silvio Taccone, Mirko Belliato, Justyna Swol","doi":"10.1097/MAT.0000000000002905","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002905","url":null,"abstract":"<p><p>Severe pulmonary hemorrhage may lead to refractory hypoxemia and/or hemodynamic collapse and cause high mortality. However, the use of extracorporeal membrane oxygenation (ECMO) in this patient population is rare. The aim of this study is to better define and understand this patient population by exploring the baseline characteristics, complications, and outcomes of patients who receive ECMO support due to pulmonary hemorrhage, based on data extracted from the extracorporeal life support organization (ELSO) registry. Between 2003 and 2023, 96 patients received ECMO due to pulmonary hemorrhage. Complications occurred in 54% of the patients, mainly acute kidney injury (AKI) with need for renal replacement therapy (RRT; 28%) and bleeding (pulmonary, gastrointestinal) (15%). Respiratory infections occurred in 37.1% of the patients. The most common diagnostic/therapeutic procedures were computed tomography scans in 9%, bronchoscopy in 41%, surgery in 8%, and apheresis in 6% of the patients. Interventional radiology procedures were performed in only 2% of the patients. Interpretation of these data should be performed cautiously, as underreporting is a known limitation of the ELSO Registry. Forty-seven patients (49%) were weaned from ECMO, and 46 (48%) survived until discharge. Survival and complication rates are comparable to the overall ECMO cohort in the ELSO Registry, which makes ECMO a feasible strategy in this patient population.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Right Heart Failure Following Left Coronary Myocardial Infarction in Left Ventricular Assist Device-Supported Patients: A Case Series and Mechanistic Insight. 左心室辅助装置支持的患者左冠状动脉心肌梗死后急性右心衰:一个病例系列和机制洞察。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-06 DOI: 10.1097/MAT.0000000000002910
Omar Fakhreddine, Jason Liu, Andrew Civitello, Nikolaos Diakos
{"title":"Acute Right Heart Failure Following Left Coronary Myocardial Infarction in Left Ventricular Assist Device-Supported Patients: A Case Series and Mechanistic Insight.","authors":"Omar Fakhreddine, Jason Liu, Andrew Civitello, Nikolaos Diakos","doi":"10.1097/MAT.0000000000002910","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002910","url":null,"abstract":"<p><p>Right heart failure (RHF) is a major cause of morbidity and mortality in patients supported with durable left ventricular assist devices (LVADs). While right coronary artery infarction is a recognized cause of acute RHF, the ventricular consequences of left coronary system infarction in LVAD-supported patients are not well characterized. We describe two patients supported with HeartMate III LVADs who developed acute RHF within 24-48 hours after successful revascularization of acute left coronary system occlusions (mid-left anterior descending artery and left main coronary artery). Both had previously stable LVAD function and no evidence of advanced RHF. After revascularization, each developed hypotension, rising central venous pressure, reduced LVAD flows, and echocardiographic evidence of severe right ventricular (RV) dilation and dysfunction with septal shift toward the left ventricle. Hemodynamic deterioration reversed with inotropic support, diuresis, and LVAD speed adjustment, without mechanical RV support. These cases suggest left coronary acute myocardial infarction (AMI) may precipitate acute RHF in LVAD-supported patients through septal ischemia with impaired ventricular interdependence, acute increases in RV afterload, and relative RV ischemia despite patent right coronary arteries. Heightened surveillance and early echocardiographic assessment after left-sided AMI in LVAD recipients may enable prompt recognition and timely intervention.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Output From Right Ventricular Pressure: Not the Solution for Venovenous Extracorporeal Membrane Oxygenation. 右心室压力引起的心输出量:不是静脉-静脉体外膜氧合的解决方案。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-05 DOI: 10.1097/MAT.0000000000002911
Mickael Lescroart, Benjamin Pequignot, Frederique Groubatch, Nguyen Tran, Alma Revol, Camille Doyen, Bruno Levy
{"title":"Cardiac Output From Right Ventricular Pressure: Not the Solution for Venovenous Extracorporeal Membrane Oxygenation.","authors":"Mickael Lescroart, Benjamin Pequignot, Frederique Groubatch, Nguyen Tran, Alma Revol, Camille Doyen, Bruno Levy","doi":"10.1097/MAT.0000000000002911","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002911","url":null,"abstract":"<p><p>Cardiac output (CO) monitoring is challenging during venovenous extracorporeal membrane oxygenation (VV ECMO), as thermodilution techniques are unreliable. Cardiac output from right ventricular pressure (RVP) waveforms has recently been considered. We evaluated whether RVP-derived CO (CORV) accurately reflects cardiac output measured by echocardiography (COUS) during VV ECMO. Ten anesthetized pigs underwent femoro-jugular VV ECMO implantation. A Swan-Ganz IQ catheter provided continuous CORV monitoring throughout the experiment. Cardiac output was modulated using either dobutamine (5-20 µg/kg/min) or landiolol (10-40 µg/kg/min) infusions. Agreement between CORV and COUS was assessed using Pearson correlation and Bland-Altman analysis. Overall, 596 paired CO measurements were performed in seven animals. Cardiac output ranged from 1.05 to 9.46 L/min. Correlation between CORV and COUS was poor (R = 0.24; R2 = 0.057; p < 0.05). Bland-Altman analysis showed a mean bias of +1.94 L/min with wide limits of agreement (-1.44 to +5.32 L/min). Correlations between individual right ventricular pressure waveform components and COUS were heterogeneous and weak to moderate (diastolic RVP, R = 0.36; right ventricle +dP/dt [delta pressure/delta time] R = 0.40; systolic RVP R = 0.60). CORV is not reliable during VV ECMO in our experiment. Further studies are needed to assess CORV performances.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal Decline Before Heart Transplantation in Left Ventricular Assist Device-Supported Recipients: United Network for Organ Sharing Analysis. 左心室辅助装置支持的受者心脏移植前肾功能下降:器官共享分析联合网络。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-05 DOI: 10.1097/MAT.0000000000002897
Rabea Asleh, Sudhir S Kushwaha, Fouad Khalil, Blake Filderman, Ohad Regev, Alexandros Briasoulis, Hilmi Alnsasra
{"title":"Renal Decline Before Heart Transplantation in Left Ventricular Assist Device-Supported Recipients: United Network for Organ Sharing Analysis.","authors":"Rabea Asleh, Sudhir S Kushwaha, Fouad Khalil, Blake Filderman, Ohad Regev, Alexandros Briasoulis, Hilmi Alnsasra","doi":"10.1097/MAT.0000000000002897","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002897","url":null,"abstract":"<p><p>Although baseline renal impairment and post-heart transplantation (HT) dialysis are established clinical predictors, the prognostic impact of pre-HT renal decline in patients bridged with left ventricular assist devices (LVADs) remains unclear. We retrospectively analyzed patients from the United Network for Organ Sharing registry who underwent HT following LVAD support between 2009 and 2024. Renal decline was defined as a greater than or equal to 40% reduction in estimated glomerular filtration rate (eGFR) from listing to HT. Among 10,454 patients, 624 (6.0%) experienced pre-HT renal decline. Patients with renal decline had longer waitlist durations (median 297 vs. 197 days; p < 0.001), lower eGFR at HT (42.0 vs. 70.6 ml/min/1.73 m2; p < 0.001), and higher rates of post-HT dialysis (23.7 vs. 12.8%; p < 0.001). Independent predictors of renal decline included longer waitlist time and perioperative blood transfusions, whereas HeartMate 3 LVAD use was protective. Renal decline was independently associated with an increased risk of post-HT dialysis (adjusted odds ratio [aOR]: 2.64) and all-cause mortality (adjusted hazard ratio [aHR]: 1.16), with post-HT dialysis strongly predicting mortality (aHR: 3.48). Renal deterioration is a significant predictor of post-HT dialysis and mortality in LVAD-bridged patients. Incorporating renal trajectory into risk stratification may enhance candidate selection and promote perioperative renal protection strategies.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Global Trends and Challenges of Pediatric Ventricular Assist Device Programs: An ACTION Collaborative Survey. 当前儿科心室辅助装置项目的全球趋势和挑战:一项ACTION合作调查。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-05 DOI: 10.1097/MAT.0000000000002909
Ah Young Kim, Alfred Asante-Korang, HaEun Jazmin Kim, Angela Lorts, Robert A Niebler, Matthew J O'Connor, Nikita Orwick, David Rosenthal, Swati Sehgal, David Sutcliffe, Christina VanderPluym, Matthew Zinn, Anna Joong
{"title":"Current Global Trends and Challenges of Pediatric Ventricular Assist Device Programs: An ACTION Collaborative Survey.","authors":"Ah Young Kim, Alfred Asante-Korang, HaEun Jazmin Kim, Angela Lorts, Robert A Niebler, Matthew J O'Connor, Nikita Orwick, David Rosenthal, Swati Sehgal, David Sutcliffe, Christina VanderPluym, Matthew Zinn, Anna Joong","doi":"10.1097/MAT.0000000000002909","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002909","url":null,"abstract":"<p><p>Ventricular assist devices (VADs) have become an established therapy for children with end-stage heart failure, yet multinational data describing pediatric VAD programs remain limited. We conducted a 12 question survey through the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) involving 74 international healthcare professionals from pediatric VAD programs outside North America. The survey assessed device and resource availability, multidisciplinary team composition, program challenges, and future priorities. Fifteen responses representing 15 centers from 14 countries were received, including 13 centers with established pediatric VAD programs. Most centers (91%, 10/11) managed 1-5 pediatric VAD patients annually. Berlin Heart EXCOR and HeartMate 3 were available in 85% (11/13) of centers, while only 46.7% (7/15) had a dedicated VAD coordinator. Major barriers included inadequate education for intensive care unit (ICU) and nursing staff and patients (69%, 9/13), financial constraints (54%, 7/13), limited device availability (46%, 6/13), and lack of outpatient VAD experience, with 31% (4/13) of centers reporting no experience discharging patients on VAD support. Substantial variation in device availability, multidisciplinary resources, and program experience exists across regions. These findings highlight important gaps in pediatric VAD care and support international collaboration to improve education, infrastructure, and access to advanced heart failure therapies.</p>","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the Letter to the Editor: Beyond VA-ECMO Cannulation: Socioeconomic Disparities and Pathways to Definitive Therapy. 对编辑的回复:超越VA-ECMO插管:社会经济差异和最终治疗途径。
IF 2.2 3区 医学
ASAIO Journal Pub Date : 2026-11-02 DOI: 10.1097/MAT.0000000000002917
Luiz Marcelo Almeida de Araujo, Sung-Min Cho
{"title":"Response to the Letter to the Editor: Beyond VA-ECMO Cannulation: Socioeconomic Disparities and Pathways to Definitive Therapy.","authors":"Luiz Marcelo Almeida de Araujo, Sung-Min Cho","doi":"10.1097/MAT.0000000000002917","DOIUrl":"https://doi.org/10.1097/MAT.0000000000002917","url":null,"abstract":"","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149317582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书